These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 14631235
21. [The contribution of skin autograft in open air in the treatment of the Buruli ulcer]. Kibadi Kapay A, Mputu-Yamba JB, Muyembe T, Bonga G, N'Siala A. Bull Soc Pathol Exot; 2005 Apr; 98(1):21-5. PubMed ID: 15915968 [Abstract] [Full Text] [Related]
22. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH, Amofah GK, Ofori-Adjei D, Dobos K, Guarner J, Martin S, Pathak S, Klutse E, Etuaful S, van der Graaf WT, van der Werf TS, King CH, Tappero JW, Ashford DA. Clin Infect Dis; 2005 May 15; 40(10):1445-53. PubMed ID: 15844067 [Abstract] [Full Text] [Related]
23. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice]. Nakanaga K, Saito H, Ishii N, Goto M. Kekkaku; 2004 May 15; 79(5):333-9. PubMed ID: 15211873 [Abstract] [Full Text] [Related]
24. [Impact of Buruli ulcer secondary prevention program in an endemic area in Côte d'Ivoire]. Kanga JM, Kacou ED, Yao JK, Kassi K, Kouamé K, Kaloga M, Kamelan CO. Bull Soc Pathol Exot; 2007 Oct 15; 100(4):277-81. PubMed ID: 17982859 [Abstract] [Full Text] [Related]
25. Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient. Toll A, Gallardo F, Ferran M, Gilaberte M, Iglesias M, Gimeno JL, Rondini S, Pujol RM. Clin Exp Dermatol; 2005 Nov 15; 30(6):649-51. PubMed ID: 16197379 [Abstract] [Full Text] [Related]
26. [Fighting against Buruli ulcer: the Côte-d'Ivoire experience]. Kanga JM, Kacou ED, Kouamé K, Kassi K, Kaloga M, Yao JK, Dion-Lainé M, Avoaka LE, Yoboué-Yao P, Sangaré A, Ecra JE, Ahogo C, Djédjé MS, Kadiri AJ, Ayé C. Bull Soc Pathol Exot; 2006 Mar 15; 99(1):34-8. PubMed ID: 16568681 [Abstract] [Full Text] [Related]
33. [Contribution of heparin therapy in the medical treatment of Buruli ulcer apropos of 1 case]. Kanga JM, Dion-Laine M, Kacou DE, Menan EI. Bull Soc Pathol Exot; 2001 Mar 06; 94(1):32-5. PubMed ID: 11346980 [Abstract] [Full Text] [Related]
34. Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases. Coloma JN, Navarrete-Franco G, Iribe P, López-Cepeda LD. Int J Lepr Other Mycobact Dis; 2005 Mar 06; 73(1):5-12. PubMed ID: 15898843 [Abstract] [Full Text] [Related]
35. [Knowledge-attitudes-practices survey of the Songololo population (D.R. Congo) about Buruli ulcers]. Kibadi Kapay A. Bull Soc Pathol Exot; 2004 Nov 06; 97(4):302-5. PubMed ID: 17304757 [Abstract] [Full Text] [Related]
36. Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, Etuaful S, Raghunathan PL, Whitney EA, Ampadu EO, Asamoa K, Klutse EY, te Meerman GJ, Tappero JW, Ashford DA, van der Steege G. Genes Immun; 2006 Apr 06; 7(3):185-9. PubMed ID: 16395392 [Abstract] [Full Text] [Related]
38. Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation. Walsh DS, Dela Cruz EC, Abalos RM, Tan EV, Walsh GP, Portaels F, Meyers WM. Am J Trop Med Hyg; 2007 Jan 06; 76(1):132-4. PubMed ID: 17255241 [Abstract] [Full Text] [Related]